FDA approves Telix brain cancer imaging drug Pixclara
Telix said the FDA approved its brain cancer imaging drug Pixclara, with the stock up in premarket trading.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.